90 related articles for article (PubMed ID: 23747222)
1. Use of volumetric-modulated arc therapy for treatment of Hodgkin lymphoma.
Lee YK; Bedford JL; Taj M; Saran FH
Med Dosim; 2013; 38(4):372-5. PubMed ID: 23747222
[TBL] [Abstract][Full Text] [Related]
2. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.
Bertelsen A; Hansen CR; Johansen J; Brink C
Radiother Oncol; 2010 May; 95(2):142-8. PubMed ID: 20188427
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis.
McGrath SD; Matuszak MM; Yan D; Kestin LL; Martinez AA; Grills IS
Radiother Oncol; 2010 May; 95(2):153-7. PubMed ID: 20116115
[TBL] [Abstract][Full Text] [Related]
5. On the use of volumetric-modulated arc therapy for single-fraction thoracic vertebral metastases stereotactic body radiosurgery.
Pokhrel D; Sood S; McClinton C; Shen X; Badkul R; Jiang H; Mallory M; Mitchell M; Wang F; Lominska C
Med Dosim; 2017 Spring; 42(1):69-75. PubMed ID: 28129972
[TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer.
Van Benthuysen L; Hales L; Podgorsak MB
Med Dosim; 2011; 36(4):404-9. PubMed ID: 21377864
[TBL] [Abstract][Full Text] [Related]
7. Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.
Shaffer R; Morris WJ; Moiseenko V; Welsh M; Crumley C; Nakano S; Schmuland M; Pickles T; Otto K
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):401-7. PubMed ID: 19268554
[TBL] [Abstract][Full Text] [Related]
8. Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal-structure dose-volume metrics.
Rosenberg MW; Kato CM; Carson KM; Matsunaga NM; Arao RF; Doss EJ; McCracken CL; Meng LZ; Chen Y; Laub WU; Fuss M; Tanyi JA
Med Dosim; 2013; 38(4):407-12. PubMed ID: 23810414
[TBL] [Abstract][Full Text] [Related]
9. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
11. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.
Weber DC; Peguret N; Dipasquale G; Cozzi L
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1578-86. PubMed ID: 19596171
[TBL] [Abstract][Full Text] [Related]
12. Comparative dosimetry of volumetric modulated arc therapy and limited-angle static intensity-modulated radiation therapy for early-stage larynx cancer.
Riegel AC; Antone J; Schwartz DL
Med Dosim; 2013; 38(1):66-9. PubMed ID: 22901745
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
14. Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment.
Clemente S; Oliviero C; Palma G; D'Avino V; Liuzzi R; Conson M; Pacelli R; Cella L
Radiat Oncol; 2018 Oct; 13(1):202. PubMed ID: 30340604
[TBL] [Abstract][Full Text] [Related]
15. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
[TBL] [Abstract][Full Text] [Related]
16. Volumetric-modulated arc therapy vs conventional fixed-field intensity-modulated radiotherapy in a whole-ventricular irradiation: a planning comparison study.
Sakanaka K; Mizowaki T; Sato S; Ogura K; Hiraoka M
Med Dosim; 2013; 38(2):204-8. PubMed ID: 23523303
[TBL] [Abstract][Full Text] [Related]
17. Comparison of anatomy-based, fluence-based and aperture-based treatment planning approaches for VMAT.
Rao M; Cao D; Chen F; Ye J; Mehta V; Wong T; Shepard D
Phys Med Biol; 2010 Nov; 55(21):6475-90. PubMed ID: 20959688
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation.
Han C; Schultheisss TE; Wong JY
Radiother Oncol; 2012 Feb; 102(2):315-20. PubMed ID: 21724284
[TBL] [Abstract][Full Text] [Related]
19. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
20. Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin's Lymphoma with mediastinal involvement: A dosimetric comparison.
Higby C; Khafaga Y; Al-Shabanah M; Mousa A; Ilyas M; Nazer G; Khalil EM
J Egypt Natl Canc Inst; 2016 Sep; 28(3):163-8. PubMed ID: 27245145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
